BRAF Mutation Affects Intratumor Heterogeneity in Papillary Thyroid Carcinoma
Analytical Cellular Pathology · 2026-01 · 2026 (1)
DOI: 10.1155/ancp/8843563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, online erschienen am 18.05.2026. Verfasst von Ying-Er Feng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Nursing, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China, z2hospital.com. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Proto-Oncogene Proteins B-raf, Genetic Heterogeneity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Intratumor heterogeneity (ITH) plays an important role in patients’ clinical outcomes. The prognostic impact of ITH and its influencing factors is unclear in papillary thyroid carcinoma (PTC), which deserves further investigation.
Methods
The Mutation Annotation Format (MAF) and clinical features were collected from The Cancer Genome Atlas Thyroid Cancer (TCGA‐THCA) cohort. We first assessed the influence of ITH on the prognosis of patients. We used the Mutant Allele Tumor Heterogeneity score to evaluate and represent ITH. Then we explored the potential factors associated with ITH. Finally, we predicted possible pathways involved in ITH.
Results
Among 4 prognostic outcomes, higher ITH was mainly related to poor disease‐free interval (DFI) (HR = 2.64, p = 0.01), and ITH had potential value for predicting DFI. Further, we identified BRAF mutation and thyroid differentiation score (TDS) as key factors independently influencing ITH (all p < 0.05), especially TDS, which had a favorable ability and obtained good net benefit in predicting ITH. TDS maintained a stable negative effect on ITH. In contrast, BRAF mutation positively correlated with ITH in univariable regression (β = 0.196). Through performing sensitivity, regression, subgroup, interaction effect, and mediation analyses, we identified that TDS played a suppression effect in the impact of BRAF mutation on ITH. Finally, we revealed that the propionate metabolism pathway was most strongly associated with ITH.
Conclusions
ITH is associated with DFI in patients with PTC and deserves more attention. TDS and BRAF mutation are the key influencing factors of ITH, but TDS exerts a suppression effect on the impact of BRAF mutation on ITH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ultrasound Nursing, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China, z2hospital.com.
- General Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine, Zheda Campus, Hangzhou, 310027, Zhejiang, China, z2hospital.com.
ORCID-Profile: Cun-Jie Wang
Zitieren
APA
Feng, Y. E., & Wang, C. J. (2026). BRAF Mutation Affects Intratumor Heterogeneity in Papillary Thyroid Carcinoma. Analytical Cellular Pathology, 2026(1). https://doi.org/10.1155/ancp/8843563
Vancouver
Feng YE, Wang CJ. BRAF Mutation Affects Intratumor Heterogeneity in Papillary Thyroid Carcinoma. Analytical Cellular Pathology. 2026;2026(1). doi:10.1155/ancp/8843563
BibTeX
@article{Feng2026,
author = {Feng, Ying-Er and Wang, Cun-Jie},
title = {BRAF Mutation Affects Intratumor Heterogeneity in Papillary Thyroid Carcinoma},
journal = {Analytical Cellular Pathology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ancp/8843563}
}
EUVIMED